![Daniel Gooding](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Gooding
Fondateur chez
NUFORMIX PLC
Fortune : 117 216 $ au 31/08/2026
Profil
Dr. Daniel Gooding is an Executive Director at Nuformix Plc.
He is on the Board of Directors at Nuformix Plc.
Dr. Gooding was previously employed as a Chief Executive Officer & Director by Nuformix Technologies Ltd. He received his doctorate degree from the University of Leeds.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUFORMIX PLC 2,01% | 11/11/2025 | 52 328 571 ( 2,01% ) | 117 216 $ | 31/08/2026 |
Postes actifs de Daniel Gooding
| Sociétés | Poste | Début |
|---|---|---|
| NUFORMIX PLC | Fondateur | 01/01/2008 |
Anciens postes connus de Daniel Gooding
| Sociétés | Poste | Fin |
|---|---|---|
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Fondateur | 01/06/2020 |
Formation de Daniel Gooding
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nuformix Plc
 Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
